Pancreatic Cancers With ATM Defects May Respond to Irinotecan, Study Finds
A new study combining real-world clinical data with CRISPR-edited cell models shows that pancreatic cancers with ATM or CHEK2 mutations ...
A new study combining real-world clinical data with CRISPR-edited cell models shows that pancreatic cancers with ATM or CHEK2 mutations ...
University of Sheffield researchers found that type I collagen in tumour scaffolding lets breast and pancreatic cancer cells switch fuel ...
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
Researchers engineered a fusogenic oncolytic vaccinia virus that displays IL-15Rα on infected tumor cells to locally trans-present IL-15, reprogramming the ...
A new review highlights fructose metabolism as a druggable weakness in KRAS G12D pancreatic tumors and proposes sodium citrate as ...
Researchers have published a two-week protocol called Trace-n-Seq that retrogradely labels neurons innervating a chosen organ and sequences them individually ...
Two landmark New England Journal of Medicine studies show the pan-RAS inhibitor daraxonrasib nearly doubles survival in previously treated metastatic ...
A case report describes a novel transjugular endovascular biopsy through the portal vein that diagnosed pancreatic cancer after standard biopsies ...
A new systematic review and meta-analysis of 27 studies finds no consistent link between oral contraceptives, menopausal hormone therapy, or ...
A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine